Vaxtex Cotfab: The financial results for the period ended September 30, 2026
Vaxtex Cotfab (VCL) filed a disclosure titled "The financial results for the period ended September 30, 2026". The company is valued at about ₹28.48 crore.
What happened
Vaxtex Cotfab (VCL) filed a disclosure with the exchanges on 13 November 2026 at 08:17 PM titled "The financial results for the period ended September 30, 2026".
Company snapshot
Vaxtex Cotfab is a micro-cap company, with a market value of about ₹28.48 crore.
The stock last traded at ₹1.55, against a 52-week range of ₹0.93–₹2.66 (41.7% below the high).
Before this filing the shares had moved +5.4% over the month and +6.1% over three months. Average daily turnover over the last 20 sessions was about ₹0.05 crore.
Promoters held 0.50% at the end of Q1 FY27. Foreign institutions owned 11.14% and domestic institutions 0.00%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 0 | 0.2 | 0.01 |
| Q2 FY26 | 2 | 0.6 | 0.03 |
| Q3 FY26 | 9 | 3.9 | 0.22 |
| Q4 FY26 | 0 | 0.8 | 0.04 |
| Q1 FY27 | 0 | -0.1 | 0 |
What history shows
BCEIE's records show 1 previous results filing from the company since May 2026.
Market-wide, 11,788 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 43% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 13 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.